SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
- SEK946.68m
- SEK913.23m
- SEK200.23m
Brief: Sedana Medical Q1 Net Income at SEK -16.1 Million
Brief: Sedana Q4 Operating Loss Widens To SEK 23.2 Mln
Brief: Sedana Medical Receives Market Approval In Italy
Brief: Sedana Medical Completes Patient Recruitment For Pediatric Isocomfort Study
Brief: Sedana Medical Receives FDA Fast Track Designation In US
Brief: Sedana Medical Gets Positive Opinion From EMA's Pediatric Committee On Reduced Pediatric Study Design
Brief: Sedana Medical Q3 EBITDA Loss Widens To SEK 25.1 Mln
Brief: Sedana Medical's Products Receive MDR Certification
Brief: Sedana Medical Q2 EBIT Loss Widens To SEK 30 Million
Brief: Sedana Medical Q1 Operating Loss Widens To SEK 22 Mln
Brief: Sedana Medical Q4 EBITDA Loss Widens To SEK 13 Mln
Brief: Sedana Medical's Sedaconda ACD Recommended By NICE
Brief: Sedana Medical Appoints Johan Spetz As New CFO
Brief: Sedana Medical Receives IND Approval For U.S. Trials
Brief: Sedana Medical Applies For Market Approval In Italy
Brief: Sedana Medical Has Carried Out Directed Share Issue Raising Gross Proceeds Of 615 MSEK
Brief: Sedana Medical Q3 EBITDA Loss Widens To SEK 14 Mln
Brief: Sedana Medical Gets Marketing Approval In Germany
Brief: Sedana Medical Q2 EBITDA Turns To Loss Of SEK 14 Mln